Company intelligence / Profile preview

EO2 Concepts

San Antonio, Texas, United Stateseo2.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

EO2 Concepts’ CDO therapy has demonstrated positive clinical results in randomized controlled and double-blind trials for chronic wound healing, showing improved healing rates and patient quality of life. The TransCu O2 system is FDA-cleared and supported by published studies for diabetic foot ulcers, venous leg ulcers, pressure ulcers, surgical wounds, skin grafts, and burns.

Therapeutic areas: DermatologyEndocrinologyCardiovascularOther
Modalities: DeviceNon-pharmacological therapy (Continuous Diffusion of Oxygen Therapy)
Industry: Therapeutic Medical Devices

Partnerships

Federal Supply Schedule (FSS): products available to over 1300 Veterans Health facilities and other government agencies

Beyond the preview

Go deeper on EO2 Concepts.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EO2 Concepts.

Explore the full profile